.jpg)
1 hour ago
3
Article content
Funding accelerates commercial expansion of voice AI and clinical documentation across North America
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
MONTREAL, Feb. 11, 2026 (GLOBE NEWSWIRE) — Montreal-based health AI company Secai today announced the closing of a $6.2M Series A financing round. The investment will support the commercial expansion of Voxira and NoteGen, strengthen engineering and product capabilities, and accelerate adoption across Canada and the United States.
Article content
Article content
Secai has seen rapid market traction, supporting clinics across North America and becoming the first and only voice AI certified by the Quebec Ministry of Health (TGV certification, August 2025). The round brings together healthcare-focused investors and strategic partners with deep expertise in clinical operations, EMR integrations, and large-scale health system deployment.
Article content
Article content
“Clinics are no longer asking whether they should use AI, but how quickly they can deploy it,” said Dr. Ragui Ibrahim, President and CEO of Secai. “Our technology helps clinics reclaim hours of administrative time, increase capacity, and reduce burnout. This funding allows us to scale that impact more broadly.”
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
Healthcare systems across North America continue to face a record shortage of clinical administrative staff, creating access challenges and operational strain. Secai’s AI infrastructure addresses this gap by automating patient communications, appointment workflows, documentation, and care coordination. Voxira delivers autonomous voice reception and patient access automation, while NoteGen enables real-time encounter capture with structured documentation and direct EMR integration.
Article content
Investors viewed healthcare as being at a pivotal moment, where AI can meaningfully improve both operational efficiency and patient outcomes. Secai’s strong clinical foundation, combined with early adoption by leading health systems, demonstrated a differentiated and credible approach to deploying AI in real-world healthcare environments.
Article content
Article content
The Series A funding will be used to expand Voxira and NoteGen nationwide, deepen integrations with major EMR platforms, and advance R&D in clinical reasoning and agentic workflows.
Article content
“With this investment, we’re building the operating system of the modern clinic,” added Dr. Ibrahim.
Article content
About Secai
Secai is a Montreal-based AI company focused on closing the gap between advanced technology and daily clinical practice. Its tools are built for practical, reliable use, helping clinics run smoothly and giving patients faster, easier access to care. The growing Secai ecosystem includes Voxira and NoteGen and supports medical practices across North America, for an improved patient experience.
Article content
Media Contact
[email protected]
Article content
Article content
Article content
Article content
Article content
Article content
English (US)